Floatz logo

18F-ASIS

Myeloma

Memorial Sloan Kettering Cancer CenterPhase 1Dormant
CC
46/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
32/ 100
Competitive Position
89/ 100

Competitive context

17 Active assets in the Myeloma cohort.

Asset / SponsorPhaseRating
Trimethoprim
Monash University
Phase 3BB
SULFAMETHOXAZOLE
Monash University
Phase 3BB
Lipitor
Fred Hutchinson Cancer Center
Phase 2BB
HUMAN IMMUNOGLOBULINS
Monash University
Phase 2/3BB
Campath
Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University
Phase 2B

View all 43 →

Same molecule, other indications

18F-ASIS is also rated in:

Inflammatory Demyelinating DiseaseDormant
CCC
Indicative ·
53 / 100
View asset →
Thymus NeoplasmsDormant
CCC
Indicative ·
53 / 100
View asset →
Non-small Cell Lung CancerDormant
CCC
Indicative ·
50 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →